Table 2 ARIMA model (p, d, q) for each country
From: Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100
ARIMA model (p,d,q) | Country | No. of Country |
|---|---|---|
(2, 1, 0) | Afghanistan, Armenia, Estonia, Finland, Gabon, Haiti, Jamaica, Lithuania, Saudi Arabia, Slovakia | 10 |
(1, 1, 0) | Albania, United Arab Emirates, Austria, Cameroon, Costa Rica, Czech Republic, Algeria, Guyana, India, Israel, Kyrgyzstan, Maldives, Mauritania, Mauritius, New Zealand, Panama, Serbia, Sweden, Tanzania | 19 |
(0, 1, 1) | Argentina, Denmark, Greece, Kenya, Cambodia, Kuwait, Laos, Myanmar, Paraguay, El-Salvador | 10 |
(0, 1, 0) | Australia, Dominican Republic, Fiji, Croatia, Hungary, Nigeria, Nicaragua, Papua New Guinea, Poland, Russian Federation, Senegal | 12 |
(1, 2, 0) | Burundi, Belgium, Bangladesh, Brazil, Congo, Egypt, Ghana, Gambia, Japan, Mali, Mozambique, Malawi, Malaysia, Peru, Philippines, Portugal, Tajikistan, Trinidad and Tobago, United States America | 19 |
(0, 2, 0) | Benin, Bulgaria, Bahrain, Belize, Barbados, Canada, Switzerland, Chile, Côte d’Ivoire, Columbia, Germany, Spain, France, Honduras, Ireland, Iran, Liberia, Lesotho, Luxembourg, Latvia, Namibia, Niger, Norway, Pakistan, Qatar, Rwanda, Slovenia, Swaziland, Syrian Arab Republic, Togo, Thailand, Turkey, Uruguay, South Africa, Zambia | 35 |
(0, 2, 1) | Bolivia, Central African Republic, Ecuador, Guatemala, Iraq, Italy, Mexico, Nepal, Tunisia, Ukraine, Zimbabwe | 11 |
(0, 2, 2) | Botswana, China, Iceland, Republic of Moldova, Sierra Leone, Vietnam, Yemen | 7 |
(1, 2, 1) | Democratic Republic of Congo, Indonesia, Romania, Uganda, Jordan | 5 |
(3, 3, 0) | Cuba | 1 |
(2, 1, 1) | Cyprus, Kazakhstan | 2 |
(1, 0, 0) | United Kingdom | 1 |
(2, 0, 0) | Republic of Korea | 1 |
(2, 2, 2) | Sri Lanka | 1 |
(2, 2, 1) | Latvia | 1 |
(1, 1, 1) | Malta | 1 |
(0, 1, 2) | Mongolia | 1 |
(3, 1, 0) | Netherlands | 1 |
(2, 0, 2) | Sudan, Singapore | 1 |
(2, 2, 0) | Venezuela | 1 |
Total Country | 140 | |